{'output': [['Halozyme Therapeutics Inc', 'COMP', 'Projects', '25 to 30 Percent Enhanze Royalty Growth', 'ECON_INDICATOR', 'In', '2018', 'TIME'], ['Halozyme Therapeutics Inc', 'COMP', 'Forecasts', 'Potential Royalty Revenue for Enhanze', 'ECON_INDICATOR', 'To Reach', 'Nearly $1 Billion', 'ECON_INDICATOR', 'In', '2027', 'TIME'], ['Halozyme Therapeutics Inc', 'COMP', 'Expects', 'Additional Partners', 'ORG', 'To Begin', 'Three Phase 1 Studies', 'EVENT', 'With New Targets for Enhanze', 'PRODUCT', 'In', '2018', 'TIME']]}